Enabling Better Chemistry
If software applications are going to truly deliver a positive impact on chemists' ...
By: Phil McHale of PerkinElmer Informaticsfrom Issue 22.3
Update your profile - win an iPad
Takes only one minute and limited time
By: Richard A. Stanton of PerkinElmer Informaticsfrom Issue 22.2
IR, UV/VIS, and NMR spectra predictions
ChemBio3D brings workstation-quality molecular graphics and rigorous computational ...
By: Jesse Gordon of PerkinElmer Informaticsfrom Issue 20.4
Ensemble for BiologyE-Notebook
A strong collaborative approach combining systematic experimental input from biologists ...
By: Megean J. Schoenberg of PerkinElmer Informaticsfrom Issue 22.1
Company: Semafore Pharmaceuticals
Dr. Tax Georgiadis obtained his BS degree from Indiana University and his PhD from UCLA. During his twelve years in the pharmaceutical industry, he has held positions at Johnson & Johnson, Provid Research and 3Dimensional Pharmaceuticals. Currently, he is a Principal Research Scientist at Semafore Pharmaceuticals where he leads one of the oncology research projects. Semafore is a drug discovery and development company that is targeting the cell signaling pathway to create innovative oncology products expected to have major benefits over existing therapies.
Email Tax M. Georgiadis, Ph.D.
Your Full Name:
All trademarks are the property of their respective holders. Copyright 1998-
Manage Your Account | Contact Us |